Gene Review:
NOMO1 - NODAL modulator 1
Homo sapiens
Synonyms:
Nodal modulator 1, Nomo, PM5, pM5 protein
- Identification of novel polymorphisms in the pM5 and MRP1 (ABCC1) genes at locus 16p13.1 and exclusion of both genes as responsible for pseudoxanthoma elasticum. Perdu, J., Germain, D.P. Hum. Mutat. (2001)
- Evaluation of irradiated heart volumes in stage I breast cancer patients treated with postoperative adjuvant radiotherapy. Gyenes, G., Gagliardi, G., Lax, I., Fornander, T., Rutqvist, L.E. J. Clin. Oncol. (1997)
- Biological activities of 1,1,6-trisubstituted indanes: beyond magainin 2. Numao, N., Hirota, Y., Iwahori, A., Kidokoro, S., Sasatsu, M., Kondo, I., Itoh, S., Itoh, E., Katoh, T., Shimozono, N., Yamazaki, A., Takao, K., Kobayashi, S. Biol. Pharm. Bull. (1999)
- Nicalin and its binding partner Nomo are novel Nodal signaling antagonists. Haffner, C., Frauli, M., Topp, S., Irmler, M., Hofmann, K., Regula, J.T., Bally-Cuif, L., Haass, C. EMBO J. (2004)
- FDP D-dimer induces the secretion of interleukin-1, urokinase-type plasminogen activator, and plasminogen activator inhibitor-2 in a human promonocytic leukemia cell line. Hamaguchi, M., Morishita, Y., Takahashi, I., Ogura, M., Takamatsu, J., Saito, H. Blood (1991)
- Differentially expressed genes in hormone refractory prostate cancer: association with chromosomal regions involved with genetic aberrations. Stubbs, A.P., Abel, P.D., Golding, M., Bhangal, G., Wang, Q., Waxman, J., Stamp, G.W., Lalani, E.N. Am. J. Pathol. (1999)
- Granulocyte colony-stimulating factor directly affects human monocytes and modulates cytokine secretion. Saito, M., Kiyokawa, N., Taguchi, T., Suzuki, K., Sekino, T., Mimori, K., Suzuki, T., Nakajima, H., Katagiri, Y.U., Fujimura, J., Fujita, H., Ishimoto, K., Yamashiro, Y., Fujimoto, J. Exp. Hematol. (2002)
- Increased sensitivity of multidrug-resistant myeloid leukemia cell lines to lovastatin. Maksumova, L., Ohnishi, K., Muratkhodjaev, F., Zhang, W., Pan, L., Takeshita, A., Ohno, R. Leukemia (2000)
- Efficient deuterium-carbon REDOR NMR spectroscopy. Sack, I., Vega, S. J. Magn. Reson. (2000)
- Spectroscopic studies and PM5 semiempirical calculations of new Schiff bases of gossypol with polyoxaalkylamines. Przybylski, P., Bartl, F., Brzezinski, B. Biopolymers (2002)
- The schiff base of gossypol with 3,6,9,12,15,18,21,24-octaoxa-pentacosylamine complexes and monovalent cations studied by electrospray ionization-mass spectrometry, (1)H nuclear magnetic resonance, Fourier transform infrared, as well as PM5 semiempirical methods. Przybylski, P., Brzezinski, B., Bartl, F. Biopolymers (2004)
- Spectroscopic, mass spectrometry, and semiempirical investigation of a new ester of Monensin A with ethylene glycol and its complexes with monovalent metal cations. Huczyński, A., Przybylski, P., Brzezinski, B., Bartl, F. Biopolymers (2006)
- Expression of HOX genes in acute leukemia cell lines with and without MLL translocations. Quentmeier, H., Dirks, W.G., Macleod, R.A., Reinhardt, J., Zaborski, M., Drexler, H.G. Leuk. Lymphoma (2004)
- Phase II study of a new combined primary chemotherapy regimen, intravenous methotrexate and vincristine and intraarterial adriamycin and cisplatin, for locally advanced urinary bladder cancer: preliminary results. Kuroiwa, T., Naito, S., Hasuo, K., Kishikawa, T., Masuda, K., Kumazawa, J. Cancer Chemother. Pharmacol. (1995)
- Neoadjuvant medium-dose methotrexate, cisplatin in category T3b-T4a (N0M0) bladder cancer. Pizzocaro, G., Pisani, E., Dormia, E., Piva, L., Maggioni, A., Minervini, G. Prog. Clin. Biol. Res. (1990)